FactSet Research (FDS) reported $529.81 million in revenue for the quarter ended May 2023, representing a year-over-year increase of 8.4%. EPS of $3.79 for the same period compares to $3.76 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $527.76 million, representing a surprise of +0.39%. The company delivered an EPS surprise of +4.70%, with the consensus EPS estimate being $3.62.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company’s financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock’s price performance.
Here is how FactSet performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Total Annual Subscription Value: $2.12 billion versus $2.08 billion estimated by five analysts on average.
- Total Clients: 7770 versus the three-analyst average estimate of 7880.26.
- Total Users: 185000 versus 190261.6 estimated by three analysts on average.
- ASV – Domestic: $1.34 billion versus $1.33 billion estimated by three analysts on average.
- ASV – International: $751.10 million versus the three-analyst average estimate of $746.78 million.
- ASV from buy-side clients: 82.1% versus the two-analyst average estimate of 82.98%.
- ASV from sell-side clients: 17.9% versus 17.03% estimated by two analysts on average.
- Revenues from clients- International: 192.1 million versus the two-analyst average estimate of 187.7 million.
- Revenues from clients- US: 337.7 million versus 338.44 million estimated by two analysts on average.
View all Key Company Metrics for FactSet here>>>
Shares of FactSet have returned +0.5% over the past month versus the Zacks S&P 500 composite’s
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
FactSet Research Systems Inc. (FDS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Image and article originally from www.nasdaq.com. Read the original article here.